Detection of the Sulfhydryl Groups in Proteins
A R T I C L E S
Scheme 1. Synthesis of L-[3-13C;3,3-2H2]Cysteinea
a Reagents and conditions: (a) BnOH, HCl gas, 97%; (b) (i) N-(diphenylmethylene)glycine tert-butyl ester, chiral-PTC, 50% aqueous KOH, toluene; (ii)
0.5 M citric acid, dioxane, 76%; (c) (i) Boc2O, DMAP, DMF, (ii) Pd/C, H2 (4 atm), 50 °C, 76%; (d) TsCl, pyridine, 75%; (e) AcSK, DMF, 87%; (f) TFA,
room temperature, then HCl, ∆, 73%.
Preparation of E. coli Peptidyl-Prolyl cis-trans Isomerase b,
EPPIb, Selectively Labeled with Isotope-Labeled Amino Acids. The
EPPIb’s selectively labeled with each of the isotope-labeled
cysteines or [1-13C]tyrosine were prepared by the E. coli cell-free
protein expression system, as described previously.18-20 A 5 mL
reaction mixture, consisting of the cell extract from E. coli BL21
Star (DE3) (Invitrogen) and all other components, was placed in a
dialysis tube and dialyzed against 20 mL of outer medium for 8 h
at 37 °C. A total of 75 mg of the amino acid mixture, consisting of
about 2 mg each of the isotope-labeled cysteines or tyrosine and
19 other unlabeled amino acids, was used for each reaction, which
yielded 3-4 mg each of selectively labeled EPPIb’s. The obtained
labeled EPPIb’s were dissolved in 50 mM sodium phosphate buffer,
prepared from 100% H2O, 100% D2O, or H2O/D2O (1:1), respec-
tively, containing 100 mM NaCl and 0.1 mM NaN3, pH 7.5 (meter
reading).
Recently, we developed a unique method for identifying and
assigning the hydroxyl groups of tyrosine (Tyr) residues that
slowly exchange with the surrounding solvent hydrogens.13 The
most crucial prerequisite for observing and assigning the 13Cꢁ
peak Tyr in a high-resolution manner was to use the stereoarray
isotope labeled (SAIL) Tyr, (2S,3R)-[R,ꢀ,ꢁ-13C;ꢀ2,ꢀ1,2-
∼2H;15N]Tyr, which has an optimized labeling pattern for such
experiments.13,14 A similar strategy could also be applied to
observe the deuterium isotope shifts for the Cꢀ signals of Cys
residues in a protein: for example, the 18.2 kDa E. coli peptidyl
cis-trans isomerase b (EPPIb). One might expect to observe
the isotope shifts of the Cꢀ signals for the Cys residues in EPPIb
labeled with either uniformly 13C,15N-labeled Cys or SAIL Cys,
i.e. (2R,3R)-[1,2,3-13C;3-2H;15N]Cys.15 However, this was actu-
ally not the case, since the NMR line widths of the side-chain
Cꢀ atoms with directly bonded proton(s) were too broad to
observe small isotope shifts. Therefore, we optimized the isotope
labeling pattern of Cys in order to obtain narrower line widths
for the Cꢀ signals, which allowed us to identify the SH groups
of Cys residues in proteins with slow hydrogen exchange rates
and accurately determine their fractionation factors.
The sample concentrations varied from 0.2 to 0.7 mM, depending
on the available labeled proteins, but there was no concentration
dependence for the NMR spectra in this concentration range. In
the case of the 100% H2O solution, a 4.1 mm o.d. Shigemi tube
containing the protein solution was inserted into a 5 mm o.d. outer
2
tube containing pure D2O for the H lock signal.
NMR Measurements. All 1D-13C NMR spectra were measured
at 40 °C on a DRX600 spectrometer (Bruker Biospin; 150.9 MHz
for 13C), equipped with a 5 mm TCI cryogenic triple-resonance
probe. The WALTZ16 decoupling scheme was used for 1H and/or
2H during acquisition.21 The carrier frequency was set to 30 ppm
with a sweep width of 4500 Hz, and free induction decays were
acquired for 226 ms at a repetition time of 3 s. 1D-13C NMR spectra
with adequate signal-to-noise ratios were obtained within 6-24 h,
depending on the concentrations of the samples. In order to ensure
complete hydrogen-deuterium equilibration, we measured the time
course of the deuterium exchange of the sulfhydryl and amide
groups of the two Cys residues in D2O, as shown in the Supporting
Information. On the basis of this experiment, all of the protein
samples dissolved in H2O/D2O (1:1) were incubated for at least 1
day at 40 °C to ensure that the hydrogen-deuterium equilibrium
was completed before the NMR measurements.
Materials and Methods
Synthesis of Isotope-Labeled Cysteines. L-[3-13C]Cys and L-[3-
13C;3,3-2H2]Cys were synthesized from [13C]paraformaldehyde and
[13C;2H]paraformaldehyde, respectively, via the stereoselective
alkylation of the glycine-benzophenone Schiff base, using a chiral
phase-transfer catalyst ((11bR)-(-)-4,4-dibutyl-4,5-dihydro-2,6-
bis(3,4,5-trifluorophenyl)-3H-dinaphth[2,1-c:1′,2′-e]azepinium bro-
mide), as shown in Scheme 1 for L-[3-13C;3,3-2H2]Cys.16,17 After
protection of the amino group, the obtained serine derivative 3 was
converted to the cysteine derivative 6 by transforming the side-
chain moiety.15 The deprotection of compound 6 was achieved by
refluxing with 2 M HCl to give L-[3-13C;3,3-2H2]cysteine 7 as the
hydrochloride salt. The optical purity for the R-position was
determined to be 88% ee, by an HPLC analysis on a chiral stationary
column (DAICEL CROWNPAK CR+).
The 13C NMR exchange spectroscopy (EXSY) experiment was
performed for a 0.7 mM H2O/D2O (1:1) solution of the EPPIb
selectively labeled with [3-13C;3,3-2H2]Cys, with the same pulse
scheme used previously.13 During the chemical shift encoding (t1)
L-(2R,3R)-[3-13C;3-2H]Cys was synthesized by the previously
described method for preparing SAIL Cys, i.e. L-(2R,3R)-[1,2,3-
13C;3-2H;15N]Cys, using the unlabeled ethyl hippurate in lieu of
ethyl [1,2-13C;3-2H;3-15N]hippurate.15
1
and the acquisition of free induction decay (t2), decoupling on H
21
2
and H by the WALTZ16 scheme was applied. The data points
and the spectral widths were 512 (t1) × 4096 (t2) points and 1200
(13) Takeda, M.; Jee, J.; Ono, M. A.; Terauchi, T.; Kainosho, M. J. Am.
Chem. Soc. 2009, 131, 18556–18562.
(14) Kainosho, M.; Torizawa, T.; Iwashita, Y.; Terauchi, T.; Ono, A. M.;
Gu¨ntert, P. Nature 2006, 440, 52–57.
(18) Torizawa, T.; Shimizu, M.; Taoka, M.; Miyano, H.; Kainosho, M.
J. Biomol. NMR 2004, 30, 311–325.
(15) Terauchi, T.; Kobayashi, K.; Okuma, K.; Oba, M.; Nishiyama, K.;
Kainosho, M. Org. Lett. 2008, 10, 2785–2787.
(19) Takeda, M.; Ikeya, T.; Gu¨ntert, P.; Kainosho, M. Nat. Protoc. 2007,
2, 2896–2902.
(16) Connor, D. S.; Klein, G. W., Jr.; Medwid, J. B. Organic Syntheses;
House, H. O., Ed.; Wiley: New York, 1972; Vol. 52, pp 16.
(17) Kitamura, M.; Shirakawa, S.; Maruoka, K. Angew. Chem., Int. Ed.
2005, 44, 1549–1551.
(20) Kariya, E.; Ohki, S.; Hayano, T.; Kainosho, M. J. Biomol. NMR 2000,
18, 75–76.
(21) Shaka, A. J.; Keeler, J.; Frenkiel, T.; Freeman, R. J. Magn. Reson.
1969, 52, 335–338.
9
J. AM. CHEM. SOC. VOL. 132, NO. 17, 2010 6255